It exerts its effects on neutrophils via two different cell surface receptors initially named as CXCR1 and CXCR2, mediating and regulating leukocyte recruitment and activation at sites of inflammation (46), followed by ischemia, promoting leakage, and neovascularization (47). This evidence concerns the gene CD177 and ischemia.